REPAIR: long-term effects of macitentan on the right ventricle (RV) in pulmonary arterial hypertension (PAH)

D. Kiely (Sheffield (South Yorkshire), United Kingdom), E. Cottreel (Allschwil, Switzerland), N. Galiè (Bologna, Italy), J. Marcus (Amsterdam, Netherlands), A. Peacock (Glasgow, United Kingdom), S. Rosenkranz (Cologne, Germany), A. Swift (Sheffield, United Kingdom), A. Tawakol (Boston, United States of America), A. Torbicki (Otwock, Poland), A. Vonk Noordegraaf (Amsterdam, Netherlands), G. Wetherill (Allschwil, Switzerland), R. Channick (Los Angeles, United States of America)

Source: Virtual Congress 2020 – Updated assessment and treatment of pulmonary arterial hypertension
Session: Updated assessment and treatment of pulmonary arterial hypertension
Session type: Oral Presentation
Number: 3971
Disease area: Pulmonary vascular diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Kiely (Sheffield (South Yorkshire), United Kingdom), E. Cottreel (Allschwil, Switzerland), N. Galiè (Bologna, Italy), J. Marcus (Amsterdam, Netherlands), A. Peacock (Glasgow, United Kingdom), S. Rosenkranz (Cologne, Germany), A. Swift (Sheffield, United Kingdom), A. Tawakol (Boston, United States of America), A. Torbicki (Otwock, Poland), A. Vonk Noordegraaf (Amsterdam, Netherlands), G. Wetherill (Allschwil, Switzerland), R. Channick (Los Angeles, United States of America). REPAIR: long-term effects of macitentan on the right ventricle (RV) in pulmonary arterial hypertension (PAH). 3971

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: